176 filings
Page 6 of 9
6-K
6wfjpd5nb6j8dty7
14 Aug 12
Report of Foreign Issuer for the Period Ended June 30, 2012
12:00am
6-K
yr8h8
15 May 12
Report of Foreign Issuer for the Period Ended March 31, 2012
12:00am
6-K
y3f5 js2eve
20 Apr 12
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
8bxl4kddx66es vx56
15 Mar 12
Report of Foreign Issuer for the Period Ended December 31, 2011
12:00am
6-K
ocrf06u5
1 Mar 12
Nymox Announces U.S. Phase 2 Clinical Trial of NX-1207 for New Indication - Prostate Cancer
12:00am
6-K
45ooi1j14onc4t70
21 Feb 12
Recordati and Nymox Announce The Start of European Phase III Clinical Trial for NX-1207
12:00am
6-K
pqp 9vnqapov
14 Nov 11
Report of Foreign Issuer for the Period Ended September 30, 2011
12:00am
6-K
3l1tnakrbzjis
12 Aug 11
Report of Foreign Issuer for the Period Ended June 30, 2011
12:00am
6-K
5plq9icoawavw
13 May 11
Report of Foreign Issuer for the Period Ended March 31, 2011
12:00am
6-K
kg4h2wpx0e8dgnyh
21 Apr 11
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
o6tqcgrnior ei
15 Mar 11
Report of Foreign Issuer for the Period Ended December 31, 2010
12:00am
6-K
7cx zjfp1daln342xme
17 Dec 10
Recordati and Nymox Pharmaceutical Corporation Announce European Licensing Agreement for NX-1207
12:00am
6-K
ux2uqhgrel2a
12 Nov 10
Report of Foreign Issuer for the Period Ended September 30, 2010
12:00am
6-K
ktoddbh0qoc5x x38j
13 Aug 10
Report of Foreign Issuer for the Period Ended June 30, 2010
12:00am
6-K
7ne 0504ta0inxa
14 May 10
Report of Foreign Issuer for the Period Ended March 31, 2010
12:00am
6-K
d7whubvphk5z ybazox
23 Apr 10
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
5gui30cg9qf5wt0yw
11 Mar 10
Report of Foreign Issuer for the Period Ended December 31, 2009
12:00am
6-K
mfvlm5pp703or6pdh5
13 Nov 09
Report of Foreign Issuer
12:00am
6-K
3vg2x
14 Aug 09
Report of Foreign Issuer
12:00am
6-K
wr0t285i
3 Jun 09
Report of Foreign Issuer
12:00am